靜脈內血栓溶解劑(IV rt-PA)治療急性缺血性腦中風的時機

(1)

~~~f.$*~~6ij2{6

'

6~iIi6JII~~~*~~~2I!gm

'

.~~p.g~~1llj8~1~®8'J~$*~5H4Hgm

,

1~{fijj ~I!~p.gtBI1Il2{tf~~1lE 0 )EJ.B~%~~~24/N~l§ ~ii,~e'JCT ($~~Ifi~m~83)

fn'*

0

rt-PA)EJ.

1!t~~A~1±1£JJO~~~~~if§f6J6~DtBe'J~~~ 1n~0\24/N~

,

~~j;JJ~ff~J:'tJ1n@~~®1~1~& ~~:t~19 0 m~~~~~.cfJm~1lE~'~i6JOO-~ 6$n'i6J-.~~~~a*~'$~~~'O @~~ , ~g~m ' Sm§mJ1n~.~~~~. &~~~~~'ffl~~~~~~~.'~f1E~~

.

~i~~~ft3/N~p.g

,

m§illjlff!1lE§Jm~j~\1lE

'

~

f~~J1n*i;g~~~~)EJ.1~)J6X0\9i~l 0

02 ~

Qi5€Hm

2012 ?i*~ VOL. 72

1£

t!t

W

8

00

~~ ~ ~

cfJ '

~~

I1Il

~ ~ ~ .'~~~~~~I1Il~~~I1Il~m~1lEo~.~ r@:J ilt \'S~*~ B~~ MII;!Aijt*B~fLt$~f4±;~~grp M~$A.*H~t$~f4=*m~A U~~~H~~M&~~±~~~~

mJ

~.H.*~~~~WH~t$~~M. H~ r@:J iltB.*~~~~ffiH~t$~~Mtt ~5gijJ

aM:

~.f~;[~t$~~M$M9BijJ .~:

.

~~

·m.

·~~~·

.

·~~·

~~t$~j$

(cerebrovascular

disease)A~1nFc5+A9E~9'J§g ffi'ilim~~~~~g.~~.~~'B~~= +~~*'.I1Il~~~W~~~~~§g=ffi'A ~ffiFc5~A+A9E~~~=ffi,~,~tl.I1Il~ ~~~H.~~8~~~~tt.~-A~.o~ ~*Wf,~frif§~18~~~~(risk

factors) , :::tJ:'t~~

I1Ilm~M~~~'~&~cfJmH.~~~~~' ~I1Il~~~~9Et~~~~~~~a~,@J:'t~ 9Et~&g.~ill~B.&lliW&~0~~~~ ~i6JFo~tm 0 m~Uffi'M~~~.~cfJm~~.~9Et ~'~~~~~~~~~~M'B~~.I1Il~~ ~-~~+NA~k~~'-NA~k9Et o 1996~ ~ ~

N

B5 ~

~ ~I!~

(tm

FDA)~ ~$ *~

*

*Jc

~1iZJ~~Fo~~~.*Nf~~~iji$*~~~;fD~i§jcfJmDff~

pIT

(NINDS) 9'J

I1Il;fi)g~~~ )EJ.~~

cfJ

m9'J~J5R~~~

*'6

~

,

~ ~

62 OJ

ij,

~111

p.g

)

±

~

recombinant tissue

type

plasminogen

activator (rt-PA)

)

EJ.

~

11:

~

J1n

f,±

§i§jcfJmm~~e'J 0

NINDSe'Jrt-PA~~

cfJ

~Dff~~~t~1cfJ ~1lEM*~~ ~1£3/J\8~p.g2~AIllj~5.H§1mrt-PA;fD~~~~~1 ~i?'~~ 0 )EJ.*m~~@l0fT~~O.9mgW~ILU±~~

rt-PA

'

~~4f!~$ *~ ~;~ ~ij21[j

&311Q]

Fl1~k

9'J

~

iHAt ' )EJ.*§;fD~1WiU§&~30oA1~k

'

~1!t*'6~ Uffi'~.m~~m~M®a,J:'tg.M®~~

*§1Ii '

11'2~9Et~$~55U 8~]J~~~~~1~m0 ®~.a@l0fT~~O.6~B~~~~~Uffi' ~~W~~r'±W~~~:SZfJ:~~~O.9mg*j~if§m 0 2002~B~i:j~~8m)~ rt-pA)EJ.~11:~

I1Il11:§~cfJOO2@l1ff!f1E

'

2004~~l\1~1**~Hi 0

11'2

(2)

E 11

ffi~J1n11ij~

cfJ

@t~J1n

;ti;gWf;f:]

~i@jn!1YE& ~ ,~1YE

-

,i@jn!1iE(10~fH'3~" ~"

)

o

0

lma1~~~E11~J1n11ij~cfJ@\

,

cfJm,a~WB~8J3~fH£3IJ\Wf~illze3E~eli'H®~ 0

o

0

~ifti±18~80~~ 0

o

0

ij~gG~ij~ilifi!5~~~~tBJ1n 0

=

\

~,~1iE(10~JU'3~" :e§" )

o

D.~~.~'~J1ntlB~~Wf~8m~~\Wf~1iE~B~Wf~~~o.~~.~'Etl~J1n

tlcfJmBJlYE~8ffi~~51j,§~1iEM*'~l~ 0 (W~~ONIHSS

<

6:53')

o

0

~I* (i9~~OpNIHSS>25) &/~i@j~.:L~JI~V1tj~1I11~~tH~.:LcfJm (~ij1illIBli~j;:D~1/3

cpj;:ijil<l

mJJ§JN)I;.nt~.:L1tt~m:~1~) 0

o

0

cfJm~~fF8~ljH~lMlF.ll 0

o

0

~iEI3f[QJ~cfJmjpi<J3E~~~~tt~g~~~I~ 0

o

0

@z;;~cpm§.g-lm~,*jpi<J 0

o

0

cpm~~fF~48IN~~1~fflheparin

' §

~jpi<JA;51IjgGIBI~J1n~@a~FB~

(a

PTI)

.:L1~~~ 0

o

0

J1nINliz<100.000/mm3

,

0

o

0

j5iM1~tBJ1n 0

o

0

.~ij~~ !b~¥§JN~*~~J1n~~ 0

o

0

U~Il~

>

185 mmHg

~*B~~

>

110 mmHg ,

~m~~~]BJjf:]~ ( ~jiijJN*8.) 1-;A~~ittJ1nm~

~mL?]!~E.!UT 0

o

0

J1n~}

<

50mg/dl

~

>

400 mg

/ dl

0

o

D§~~@z;;6@~~~.~~tBJ1n

• •

\~tBJ1nemo

o

0

jpi<JXLEt~~OijIiH1f.I~J1n~

,

~Owarfarin

sodium

(

INR>

13)

0

o

DcfJ.~~~mm

•

.:Ljpi<J3E (~~\J1n.~, ~~~~tl~~ffi)

o

D.~~~mill§~m~.T~tBJ1n.:L.~tBJ1n~Hjpi<J3Eo

o

0

M~§*fgz}~ffi~BJ~bijJN~J1n~ 0

o

0

~z;;10 7':~~mJJ~j;:~V1tj~~~~@IH~ (E)J5~iEI.:L~11/MJLf~~pfTl:fIli§BJBJH:IDJ~~1~ )

,

®iEIffi'lgG~r!i15G~~~~~M~ 0

o

0

@~~~~~~tlB'9/I)ijffijmiiILj (m~2

:53'*i)

':53'~

\

~n10 7':~~~j~jt~ffitl.:L15GllIDtMj

J1n.g~ (~

• •

TmijJN~Hm~g~) 0

o

0

tH~ijfjpi<J

,

§j5H~rr~

\

IlH~i~

\

HF~ijJN~~ ( N~M1ijMB5~) &~1'1§f~ 0

o

DtBJ1ntl~

• •

jpi<J.'~.,*jpi<Jtt(~~

• •

~~~tBJ1nttm

• •

jpi<J~~m~)~~~tB®tl §N~ 0

o

0

mi*i11/~'~.~

,

1l2,'§9:i 0

o

D~11§~~~o

o

0

~iEI3 f[QJ~~~~~~~~)~m0

o

0

ib§JN~

,

m/mJJijJN~% 0

o

0

~tBJ1nrtn.:L§~~ 0

o

0

~j~

•

.:L~~IBActilyse ~lmt~~u~~

•

~o •

o

0 Hflli

(W~~oi±m~*~~1¢*lit~Oi2~~JJOtB

J1n~~~~~,~~.m~\H~~~.